ArticleMolecular therapy. Advances2026

Co-delivery of lentiviral vectors and Cas9-containing virus-like particles enables rapid, scalable manufacture of gene-edited CAR T cells.

Francesca Ferrara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.